Curated MicroRNAs in Urine and Blood Fail to Validate as Predictive Biomarkers for High-Risk Prostate Cancer
Figure 7
Receiver operating characteristic (ROC) curve for profiling of miRs in urine.
Prostate cancer patients from the original cohort (blue). Prostate cancer patients from the validation cohort (red).